-
2
-
-
0017402583
-
The natural history of chronic airflow obstruction
-
Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-8
-
(1977)
Br Med J
, vol.1
, pp. 1645-1648
-
-
Fletcher, C.1
Peto, R.2
-
3
-
-
84862833566
-
Small-airway obstruction and emphysema in chronic obstructive pulmonary disease
-
McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365: 1567-75
-
(2011)
N Engl J Med
, vol.365
, pp. 1567-1575
-
-
McDonough, J.E.1
Yuan, R.2
Suzuki, M.3
-
4
-
-
0036729605
-
Chronic obstructive pulmonary disease-part 2: Pathology and biochemistry of emphysema
-
Hogg JC, Senior RM. Chronic obstructive pulmonary disease-part 2: pathology and biochemistry of emphysema. Thorax 2002; 57: 830-4
-
(2002)
Thorax
, vol.57
, pp. 830-834
-
-
Hogg, J.C.1
Senior, R.M.2
-
5
-
-
10644266789
-
Mediators of chronic obstructive pulmonary disease
-
Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56: 515-48
-
(2004)
Pharmacol Rev
, vol.56
, pp. 515-548
-
-
Barnes, P.J.1
-
7
-
-
0035744613
-
Disease of the airways in chronic obstructive pulmonary disease
-
Cosio Piqueras MG, Cosio MG. Disease of the airways in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001; 34: 41s-9s
-
(2001)
Eur Respir J Suppl
, vol.34
, pp. 41s-49s
-
-
Cosio Piqueras, M.G.1
Cosio, M.G.2
-
8
-
-
4344675455
-
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease
-
Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-21
-
(2004)
Lancet
, vol.364
, pp. 709-721
-
-
Hogg, J.C.1
-
9
-
-
0038070219
-
Alveolar wall apoptosis causes lung destruction and emphysematous changes
-
Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol 2003; 28: 555-62
-
(2003)
Am J Respir Cell Mol Biol
, vol.28
, pp. 555-562
-
-
Aoshiba, K.1
Yokohori, N.2
Nagai, A.3
-
11
-
-
79952336653
-
Pathogenesis of chronic obstructive pulmonary disease
-
Rennard SI. Pathogenesis of chronic obstructive pulmonary disease. Pneumonol Alergol Pol 2011; 79: 132-8
-
(2011)
Pneumonol Alergol Pol
, vol.79
, pp. 132-138
-
-
Rennard, S.I.1
-
12
-
-
80051565223
-
Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers
-
Gordon C, Gudi K, Krause A, et al. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med 2011; 184: 224-32
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 224-232
-
-
Gordon, C.1
Gudi, K.2
Krause, A.3
-
13
-
-
0034988243
-
Lung uptake of antibodies to endothelial antigens: Key determinants of vascular immunotargeting
-
Danilov SM, Gavrilyuk VD, Franke FE, et al. Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol Lung Cell Mol Physiol 2001; 280: L1335-47
-
(2001)
Am J Physiol Lung Cell Mol Physiol
, vol.280
, pp. L1335-L1347
-
-
Danilov, S.M.1
Gavrilyuk, V.D.2
Franke, F.E.3
-
14
-
-
80051559745
-
Endothelial chronic destructive pulmonary disease (E-CDPD is endothelial apoptosis a subphenotype or prequel to COPD?
-
Chandra D, Sciurba FC, Gladwin MT. Endothelial chronic destructive pulmonary disease (E-CDPD): is endothelial apoptosis a subphenotype or prequel to COPD? Am J Respir Crit Care Med 2011; 184: 153-5
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 153-155
-
-
Chandra, D.1
Sciurba, F.C.2
Gladwin, M.T.3
-
15
-
-
0034063821
-
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease the lung health study
-
Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381-90
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 381-390
-
-
Scanlon, P.D.1
Connett, J.E.2
Waller, L.A.3
-
17
-
-
80053586178
-
Pilot analysis of the plasma metabolite profiles associated with emphysematous chronic obstructive pulmonary disease phenotype
-
Paige M, Burdick MD, Kim S, et al. Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype. Biochem Biophys Res Commun 2011; 413: 588-93
-
(2011)
Biochem Biophys Res Commun
, vol.413
, pp. 588-593
-
-
Paige, M.1
Burdick, M.D.2
Kim, S.3
-
18
-
-
78650214523
-
Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke
-
Strulovici-Barel Y, Omberg L, O?Mahony M, et al. Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke. Am J Respir Crit Care Med 2010; 182: 1524-32
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 1524-1532
-
-
Strulovici-Barel, Y.1
Omberg, L.2
O'Mahony, M.3
-
19
-
-
21044438176
-
Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease
-
Koga H, Sugiyama S, Kugiyama K, et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005; 45: 1622-30
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1622-1630
-
-
Koga, H.1
Sugiyama, S.2
Kugiyama, K.3
-
20
-
-
33847610302
-
Elevated endothelial microparticles following consecutive meals are associated with vascular endothelial dysfunction in type 2 diabetes
-
Tushuizen ME, Nieuwland R, Rustemeijer C, et al. Elevated endothelial microparticles following consecutive meals are associated with vascular endothelial dysfunction in type 2 diabetes. Diabetes Care 2007; 30: 728-30
-
(2007)
Diabetes Care
, vol.30
, pp. 728-730
-
-
Tushuizen, M.E.1
Nieuwland, R.2
Rustemeijer, C.3
-
21
-
-
0037315391
-
Effects of severe hypertension on endothelial and platelet microparticles
-
Preston RA, Jy W, Jimenez JJ, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41: 211-17
-
(2003)
Hypertension
, vol.41
, pp. 211-217
-
-
Preston, R.A.1
Jy, W.2
Jimenez, J.J.3
-
22
-
-
0035840849
-
Oxidative stress and lung inflammation in airways disease
-
MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001; 429: 195-207
-
(2001)
Eur J Pharmacol
, vol.429
, pp. 195-207
-
-
MacNee, W.1
-
23
-
-
41949115834
-
Pathogenesis of COPD part i the role of protease-antiprotease imbalance in emphysema
-
Abboud RT, Vimalanathan S. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Int J Tuberc Lung Dis 2008; 12: 361-7
-
(2008)
Int J Tuberc Lung Dis
, vol.12
, pp. 361-367
-
-
Abboud, R.T.1
Vimalanathan, S.2
-
24
-
-
2442661930
-
Endothelial microparticles as markers of endothelial dysfunction
-
Horstman LL, Jy W, Jimenez JJ, et al. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004; 9: 1118-35
-
(2004)
Front Biosci
, vol.9
, pp. 1118-1135
-
-
Horstman, L.L.1
Jy, W.2
Jimenez, J.J.3
-
25
-
-
0037709857
-
Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis
-
Jimenez JJ, Jy W, Mauro LM, et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003; 109: 175-80
-
(2003)
Thromb Res
, vol.109
, pp. 175-180
-
-
Jimenez, J.J.1
Jy, W.2
Mauro, L.M.3
-
26
-
-
33644831131
-
Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease
-
Werner N, Wassmann S, Ahlers P, et al. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 112-16
-
(2006)
Arterioscler Thromb Vasc Biol
, vol.26
, pp. 112-116
-
-
Werner, N.1
Wassmann, S.2
Ahlers, P.3
-
27
-
-
0033999142
-
Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
-
Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-3
-
(2000)
Circulation
, vol.101
, pp. 841-843
-
-
Mallat, Z.1
Benamer, H.2
Hugel, B.3
-
28
-
-
33646812544
-
Circulating endothelial microparticles in acute ischemic stroke: A link to severity, lesion volume and outcome
-
Simak J, Gelderman MP, Yu H, et al. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 2006; 4: 1296-302
-
(2006)
J Thromb Haemost
, vol.4
, pp. 1296-1302
-
-
Simak, J.1
Gelderman, M.P.2
Yu, H.3
-
29
-
-
33644876174
-
Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure
-
Amabile N, Guérin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol 2005; 16: 3381-8
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 3381-3388
-
-
Amabile, N.1
Guérin, A.P.2
Leroyer, A.3
-
30
-
-
7044271283
-
Elevated plasma endothelial microparticles: Preeclampsia versus gestational hypertension
-
González-Quintero VH, Smarkusky LP, Jiménez JJ, et al. Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension. Am J Obstet Gynecol 2004; 191: 1418-24
-
(2004)
Am J Obstet Gynecol
, vol.191
, pp. 1418-1424
-
-
González-Quintero, V.H.1
Smarkusky, L.P.2
Jiménez, J.J.3
-
31
-
-
44449177817
-
Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension
-
Amabile N, Heiss C, Real WM, et al. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 2008; 177: 1268-75
-
(2008)
Am J Respir Crit Care Med
, vol.177
, pp. 1268-1275
-
-
Amabile, N.1
Heiss, C.2
Real, W.M.3
-
32
-
-
33745168947
-
Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome
-
Arteaga RB, Chirinos JA, Soriano AO, et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 2006; 98: 70-4
-
(2006)
Am J Cardiol
, vol.98
, pp. 70-74
-
-
Arteaga, R.B.1
Chirinos, J.A.2
Soriano, A.O.3
-
33
-
-
20944438125
-
Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism
-
Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005; 45: 1467-71
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1467-1471
-
-
Chirinos, J.A.1
Heresi, G.A.2
Velasquez, H.3
-
34
-
-
61649117010
-
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea
-
Ayers L, Ferry B, Craig S, et al. Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea. Eur Respir J 2009; 33: 574-80
-
(2009)
Eur Respir J
, vol.33
, pp. 574-580
-
-
Ayers, L.1
Ferry, B.2
Craig, S.3
-
35
-
-
42949090751
-
Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: Sustained vascular injury and blunted nitric oxide production
-
Heiss C, Amabile N, Lee AC, et al. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol 2008; 51: 1760-71
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1760-1771
-
-
Heiss, C.1
Amabile, N.2
Lee, A.C.3
-
36
-
-
58849150305
-
Desmosine as a biomarker of elastin degradation in COPD: Current status and future directions
-
Luisetti M, Ma S, Iadarola P, et al. Desmosine as a biomarker of elastin degradation in COPD: current status and future directions. Eur Respir J 2008; 32: 1146-57
-
(2008)
Eur Respir J
, vol.32
, pp. 1146-1157
-
-
Luisetti, M.1
Ma, S.2
Iadarola, P.3
-
37
-
-
70349632392
-
Biomarkers of lung damage associated with tobacco smoke in induced sputum
-
Comandini A, Rogliani P, Nunziata A, et al. Biomarkers of lung damage associated with tobacco smoke in induced sputum. Respir Med 2009; 103: 1592-613
-
(2009)
Respir Med
, vol.103
, pp. 1592-1613
-
-
Comandini, A.1
Rogliani, P.2
Nunziata, A.3
-
38
-
-
80053424584
-
The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema
-
Criner GJ, Cordova F, Sternberg AL, et al. The National Emphysema Treatment Trial (NETT): Part I: Lessons learned about emphysema. Am J Respir Crit Care Med 2011; 184: 763-70
-
(2011)
Am J Respir Crit Care Med
, vol.184
, pp. 763-770
-
-
Criner, G.J.1
Cordova, F.2
Sternberg, A.L.3
-
39
-
-
80052690031
-
The chronic bronchitic phenotype of COPD: An analysis of the COPDGene Study
-
Kim V, Han MK, Vance GB, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest 2011; 140: 626-33
-
(2011)
Chest
, vol.140
, pp. 626-633
-
-
Kim, V.1
Han, M.K.2
Vance, G.B.3
-
40
-
-
84855280191
-
Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease
-
Nishimura M, Makita H, Nagai K, et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185: 44-52
-
(2012)
Am J Respir Crit Care Med
, vol.185
, pp. 44-52
-
-
Nishimura, M.1
Makita, H.2
Nagai, K.3
-
41
-
-
84856780025
-
Which pulmonary function tests best differentiate between COPD phenotypes?
-
Salzman SH. Which pulmonary function tests best differentiate between COPD phenotypes? Respir Care 2012; 57: 50-60
-
(2012)
Respir Care
, vol.57
, pp. 50-60
-
-
Salzman, S.H.1
-
42
-
-
80053534329
-
Avoiding confusion in COPD: From risk factors to phenotypes to measures of disease characterisation
-
Agustí A, Celli B. Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation. Eur Respir J 2011; 38: 749-51
-
(2011)
Eur Respir J
, vol.38
, pp. 749-751
-
-
Agustí, A.1
Celli, B.2
|